Compugen's Q4 Loss Rises 23 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Compugen today reported a 23 percent increase in its fourth-quarter loss and "insignificant" revenues of $11,000 for the three-month period ended Dec. 31.

The Tel Aviv, Israel-based computational biology firm said that its revenues declined from $90,000 for the fourth quarter of 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.